Insightace Analytics Pvt. Ltd. announces the release of a market assessment report on the "Global Mechanical Thrombectomy Devices Market- by Product Type (Coil Retriever Devices, Stent Retriever Devices, Aspiration Devices, Manual Thrombectomy Devices and Others (Ultrasound Based Devices)), Application Type (Stroke, Deep Vein Thrombosis (DVT), Pulmonary Embolism (PE), Arteriovenous fistula (AVF), Peripheral Arterial Disease (PAD), Haemodialysis Treatments, Percutaneous coronary intervention (PCI) and Others), End-User (Hospitals, Ambulatory Surgical Centers, Specialty Clinics and Academic & Research Institutes), Trends, Industry Competition Analysis, Revenue and Forecast To 2030."
Get Free Access to Demo Report, Excel Pivot and ToC: https://www.insightaceanalytic.com/request-sample/1212
According to the latest research by Insightace Analytics, the global mechanical thrombectomy devices market was valued at US$ 1.26 Billion in 2021. It is expected to reach US$ 2.27 Billion by 2030, with a CAGR of 6.9 % during a forecast period of 2022-2030.
An interventional radiologist will use specialized equipment to perform a mechanical thrombectomy, a minimally invasive procedure, to remove a clot from a patient's artery. A mechanical thrombectomy device removes clots from a vein during an interventional procedure. It is typically only employed as a last option since continuous obstruction of blood flow to organs might result in a condition called necrosis. These tools will minimize the damage to the vessel wall during surgery. According to the size and distance across and depending on the damaged location, thrombectomy devices are also used to treat pneumonic embolism, deep vein thrombosis, neurovascular thrombosis disorders, and peripheral blood vessels. The most frequently used mechanical thrombectomy techniques are balloon embolectomy, aspiration embolectomy, and surgical embolectomy.